(CTRE) CareTrust REIT - Ratings and Ratios

CareTrust REIT Inc. (NYSE:CTRE) is a self-administered real estate investment trust that specializes in owning, acquiring, developing, and leasing seniors housing and healthcare-related properties. The company has established a diverse portfolio of properties leased to a wide range of operators and healthcare services providers, generating revenue through these leases.

Since its inception as a standalone public company in 2014, CareTrust REIT has experienced significant growth, expanding its tenant base to 26 operators and its real estate portfolio to 249 net-leased healthcare properties across 32 states. This portfolio comprises 27,229 operating beds/units, with an additional 6 properties classified as held for sale. The companys investments are diversified across various healthcare properties, including those related to 113 healthcare properties across 17 states, and a financing receivable related to 46 properties in one state.

Analyzing the , we observe that the stocks last price is $29.09, slightly above its SMA20 and SMA50, indicating a positive short-term trend. The ATR of 0.65 represents a 2.22% daily price movement, suggesting moderate volatility. The stock is currently 9.4% below its 52-week high of $32.08 and 23.4% above its 52-week low of $23.59, indicating a relatively stable price range.

From a fundamental perspective, CareTrust REITs reveals a market capitalization of $5.59 billion, a P/E ratio of 31.35, and a forward P/E of 12.97. The companys return on equity stands at 6.36%. These metrics suggest that the stock may be moderately valued, with a reasonable expectation of future earnings growth.

Forecasting the stocks future performance using both and , we can anticipate a potential price increase driven by the companys continued growth and stable financials. As CareTrust REIT continues to expand its portfolio and diversify its tenant base, its revenue is likely to increase, supporting the stock price. With a relatively stable price range and moderate volatility, the stock may be poised for a gradual increase towards its 52-week high, potentially reaching $31-$32 in the near term, representing a 6-10% upside from the current price.